Expectations have gotten so high that Novo Nordisks stock actually dropped when it announced that their drug candidate CagriSema (a mix of semaglutide with the experimental drug cagrilintide) only helped people lose 22% weight in a recent trial, rather than the 25% expected
Get personalized recommendations based on your health history
85 A phase 2A trial showed that PF-06865571 (a DGAT2 inhibitor) could mitigate the effect of PF-05221304 (a novel ACC1/2 inhibitor) on serum triglycerides (NCT03776175)
Frequently Asked Questions About the Tirzepatide (Mounjaro) Program in Hawaii How is tirzepatide different from semaglutide
Moreover, by stating the import alert does not create any new limits on legal compounding of GLP-1 drugs, the FDA has explicitly stated that pharmacies can continue legally compounding GLP-1s under the conditions already permitted by federal law
On average, people who took the treatment lost 14.9% of their body weight from baseline to week 68, while those who took a placebo lost only 2.4% of their body weight